Navigation Links
CEO of Traxxec, Inc. updates on Intellectual Property
Date:1/13/2009

Manchester, UK, Jan. 13 /PRNewswire-FirstCall/ - Traxxec, Inc. (Pink Sheets: TRXX) (www.traxxec.com) announces an update to shareholders and the investment community in general regarding its Intellectual Property. CEO Amy Scopes issued the following statement: "In an earlier press release I confirmed that the patent annuities in the U.S. and Europe are current, that the patent remains licensed to Rexam Plc under a fifteen year agreement and that all Intellectual Property is protected. I also confirmed that the company had retained its technology and development associations in full support of its agreement with Rexam Plc. (www.rexam.com). The company entered in to a patent exclusive license agreement as the first stage of its strategy to provide Radio Frequency Identification (RFID) based systems and products to global markets, initially within the Pharmaceutical Industry, and its first commercial product, a radio frequency enabled pharmaceutical plastic bottle, addresses the needs of pharmaceutical manufacturers required to implement RFID by providing a solution to 'tagging of goods' and offers the option of using existing packaging processes. On 22nd December 2008, in respect of the US patent application, I was informed by our International Patent Attorneys, Marks and Clerk (www.marks-clerk.com), that they had been informed that the license agreement must be recorded in the United States Patent and Trademark Office (www.uspto.gov) and that they had requested a copy of the license agreement for filing. I have forwarded the agreement and its assignments to Marks and Clerk and requested they facilitate this to enable the federal requirement to be met. This is an important element of the corporate Intellectual Property".


'/>"/>
SOURCE Traxxec Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Stryker Updates Expected 2008 Results and Provides 2009 Outlook
2. Cardinal Health Updates FY09 Outlook
3. LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
4. Go Healthy Updates Progress With University Sports Programs
5. CPF Updates Patient Education Materials to Meet Growing Demand for Pulmonary Fibrosis Information
6. LegalView Updates Brain Injury Site with Information on TBI Disabled Soldier's Family
7. PLC Systems Updates Common Stock Listing Status
8. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
9. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
10. Alexza Reports 2008 Third Quarter Financial Results and Updates Development of Product Candidates
11. Vion Updates Conference Call Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... Journal of Oral Implantology – Tooth loss is ... dental health, including complications with speech, eating, and overcompensation of mouth due to the ... teeth. As the number of tooth replacements increase, it is imperative to design an ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete ... has been honored by Enterprising Women magazine as one of its 2017 Enterprising ... women business owners. Winners have demonstrated that they have fast-growth businesses, mentor or ...
(Date:4/26/2017)... ... 2017 , ... RawTrition now brings you BioEnergy which is a powder capsule ... , RawTrition is taking nutrients to the next level! The superfoods in ... raw form (unlike the synthetically made options that are on the market). , Founder ...
(Date:4/26/2017)... Gainesville, FL (PRWEB) , ... April 26, 2017 ... ... health and human performance, is proud to announce that it has received 510(k) ... cutting-edge technologies, the MyoCycle Home and the MyoCycle Pro. , Both devices are ...
(Date:4/25/2017)... , ... April 25, 2017 ... ... in Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, ... from its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  Novartis today announced the publication of ... and Blood Institute (NHLBI) of the National Institutes ... with treatment-naïve severe aplastic anemia (SAA) achieved complete ... at the initiation of and concurrently with standard ... sequential treatment groups, or cohorts. Cohort 3 added ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... 18, 2017 Viverae ® , a leader ... integration of IBM ® Watson Campaign Automation, implementing ... communications for a personalized experience. Through digital engagement, the ... health in real time. The enhanced experience drives engagement ... members, wherever they are in their journey to health. ...
Breaking Medicine Technology: